Nutraceutical Treatment and Prevention of Benign Prostatic Hyperplasia: A Systematic Review
Abstract
Background: Benign Prostatic Hyperplasia (BPH) is a prevalent condition among aging men, characterized by prostate enlargement leading to lower urinary tract symptoms (LUTS). Conventional treatments, including α-blockers and 5α-reductase inhibitors, are commonly used but may be associated with adverse effects. Nutraceuticals bioactive compounds derived from food sources have garnered attention as potential adjuncts or alternatives in managing BPH due to their anti-inflammatory, antioxidant, and hormonal modulatory properties.
Objective: This systematic review aims to evaluate the efficacy and safety of nutraceutical interventions in the treatment and prevention of BPH, focusing on their mechanisms of action, clinical outcomes, and potential integration into therapeutic strategies.
Methods: A comprehensive literature search was conducted across PubMed, Scopus, Web of Science, and Cochrane Library for studies published between 2011 and 2025. Eligible studies included randomized controlled trials, cohort studies, case control studies, and experimental models investigating nutraceuticals such as saw palmetto, beta-sitosterol, pygeum africanum, pumpkin seed oil, and other plant-based compounds in the context of BPH. Data extraction and quality assessment were performed independently by two reviewers, and findings were synthesized narratively.
Results: A total of 22 studies met the inclusion criteria, encompassing preclinical and clinical investigations. Saw palmetto demonstrated…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Treatment of non-metastatic castration-resistant prostate cancer: facing age-related comorbidities and drug–drug interactions
- The Efficacy of Flogofilm® in the Treatment of Chronic Bacterial Prostatitis as an Adjuvant to Antibiotic Therapy: A Randomized Prospective Trial
- Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003
- Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract Plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study
- Extract from Cucurbita pepo improves BPH symptoms without affecting sexual function: a 24-month noninterventional study
- Aquablation vs. holmium laser enucleation of the prostate for benign prostatic hyperplasia: a 150-patients prospective comparative multicenter study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.